AGDA signs 7 October sports medicine pact; clinics should check athlete-care records

Anwar Gargash Diplomatic Academy (AGDA) and the UAE Sports Science and Sports Medicine Center signed a Memorandum of Cooperation in Abu Dhabi on 7 October 2026, creating a training link between diplomacy, sport, sports science and sports medicine rather than a new clinical rule.

The highest-stakes readers are COOs, medical directors and CFOs. The agreement affects operators through documentation, referral quality and athlete-facing pharmacy controls. It does not announce a reimbursement tariff, licence deadline or penalty. That distinction matters for Dubai clinics regulated by the Dubai Health Authority (DHA), Abu Dhabi and Al Ain providers regulated by the Department of Health Abu Dhabi (DOH), and northern emirates facilities regulated by the Ministry of Health and Prevention (MOHAP).

What was signed

The cooperation was reported by Emirates News Agency and carried by Zawya. Ghanim Mubarak Al Hajeri, Undersecretary of the Ministry of Sports and Chairman of the UAE Sports Science and Sports Medicine Center, attended the signing. The memorandum was signed by Dr. Mohammed Ibrahim Al Dhaheri, Deputy Director General of AGDA, and Dr. Ziad Amir Saleh, Board Member and Executive Director of the Centre.

The Memorandum will strengthen cooperation with the Academy by introducing specialised training programs.
Ghanim Mubarak Al Hajeri, Undersecretary of the Ministry of Sports

The stated audience is athletes, coaches and heads of delegations representing the UAE at international events. For healthcare operators, the relevant phrase is sports medicine. Any clinic, rehabilitation provider or pharmacy serving athletes should expect more formal expectations around medical records used in travel, delegation support, injury clearance and medication documentation.

Why clinics and insurers should care

Dubai is the first market to watch because it has the densest private outpatient base and the fastest route from sports-event demand to clinic appointment books. DHA-licensed facilities should review whether sports medicine, physiotherapy, rehabilitation and pharmacy services are correctly listed on their licences before marketing athlete programmes. DOH Abu Dhabi providers should make the same check for services delivered in Abu Dhabi and Al Ain. MOHAP remains the relevant regulator for Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain.

There are four operator checks with near-term value:

• Licensing: confirm the facility and professional scope for sports medicine, physiotherapy, rehabilitation and pharmacy services through DHA, DOH or MOHAP portals.
• Insurance: match athlete assessments, imaging, rehabilitation sessions and prescribed medicines to the payer pre-approval rules used by Daman, Thiqa or Sukoon where those networks apply.
• Pharmacy: keep a dated medication list, prescriber name, dosage and refill record for travelling athletes, especially when a medicine may be restricted abroad.
• Records: store fitness-to-participate letters, injury notes and rehabilitation plans in the patient file before issuing delegation paperwork.

Public sources do not provide a single UAE price for athlete clearance, sports physiotherapy or medication reconciliation. CFOs should pull current numbers from three places: the clinic chargemaster, the payer portal for the relevant plan, and the regulator-facing service code used for claims. If the service is cash-pay, publish an AED price before booking. If it is insured, document the approval pathway before the first visit.

What changes for patients and pharmacies

Patients will feel the impact through access and paperwork rather than a new entitlement. An athlete travelling from Dubai to an international event may need a clearer referral chain between a DHA-licensed clinic, a rehabilitation provider and a pharmacy. An Abu Dhabi athlete covered through Thiqa may face different pre-approval steps than a Dubai resident on a Sukoon network plan. Operators should avoid giving patients one answer across all emirates.

Pharmacy teams should treat the agreement as a prompt to tighten controlled-medicine and travel-medicine workflows. The UAE has separate licensing and inspection structures across DHA, DOH and MOHAP, while international sports travel can add anti-doping and import restrictions set outside the UAE. A patient-facing pharmacy should therefore record the prescribing doctor, diagnosis link and travel date when dispensing medication for competition use.

The practical next step is modest. Clinics should assign one owner, usually the COO or medical director, to review athlete-care pathways by 31 October 2026. Insurers should check whether sports-medicine claims are being routed through the right benefit category. Pharmacies should confirm that staff can find the prescriber, payer and licence record before advising travelling athletes.

Operators comparing licensed pharmacy providers can use the UAE Open Healthcare Directory, which lists 12,394+ licensed healthcare providers across the seven emirates and includes pharmacy as a searchable specialty.